These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 33087251)

  • 21. Left hepatectomy combined with hepatic artery resection for hilar cholangiocarcinoma: A retrospective cohort study.
    Peng C; Li C; Wen T; Yan L; Li B
    Int J Surg; 2016 Aug; 32():167-73. PubMed ID: 27344254
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Conditional probability of long-term survival after resection of hilar cholangiocarcinoma.
    Buettner S; Margonis GA; Kim Y; Gani F; Ethun CG; Poultsides G; Tran T; Idrees K; Isom CA; Fields RC; Krasnick B; Weber SM; Salem A; Martin RC; Scoggins CR; Shen P; Mogal HD; Schmidt C; Beal E; Hatzaras I; Shenoy R; Maithel SK; Pawlik TM
    HPB (Oxford); 2016 Jun; 18(6):510-7. PubMed ID: 27317955
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hilar cholangiocarcinoma: tumor depth as a predictor of outcome.
    de Jong MC; Hong SM; Augustine MM; Goggins MG; Wolfgang CL; Hirose K; Schulick RD; Choti MA; Anders RA; Pawlik TM
    Arch Surg; 2011 Jun; 146(6):697-703. PubMed ID: 21690446
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Appraisal of inflammation-based prognostic scores in patients with unresectable perihilar cholangiocarcinoma.
    Okuno M; Ebata T; Yokoyama Y; Igami T; Sugawara G; Mizuno T; Yamaguchi J; Nagino M
    J Hepatobiliary Pancreat Sci; 2016 Oct; 23(10):636-642. PubMed ID: 27474781
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Factors associated with survival in patients operated on for hilar cholangiocarcinoma with curative intention.
    Contreras T; Pacheco S; Briceño E; Martínez J; Guerra JF; Jarufe N
    Cir Cir; 2019; 87(5):508-515. PubMed ID: 31448794
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Postoperative Mortality after Liver Resection for Perihilar Cholangiocarcinoma: Development of a Risk Score and Importance of Biliary Drainage of the Future Liver Remnant.
    Wiggers JK; Groot Koerkamp B; Cieslak KP; Doussot A; van Klaveren D; Allen PJ; Besselink MG; Busch OR; D'Angelica MI; DeMatteo RP; Gouma DJ; Kingham TP; van Gulik TM; Jarnagin WR
    J Am Coll Surg; 2016 Aug; 223(2):321-331.e1. PubMed ID: 27063572
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The survival benefit of surgery for perihilar cholangiocarcinoma in octogenarians: Shinshu University experience.
    Yasukawa K; Shimizu A; Kubota K; Notake T; Sugenoya S; Hosoda K; Ikehara T; Hayashi H; Kobayashi R; Soejima Y
    J Surg Oncol; 2021 Jul; 124(1):67-78. PubMed ID: 33844858
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Malignant tumors of the hepatic bifurcation--results of surgical therapy and prognostic factors].
    Beckurts KT; Hölscher AH; Bauer TH; Siewert JR
    Chirurg; 1997 Apr; 68(4):378-84. PubMed ID: 9206632
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Postoperative Liver Failure Risk Score: Identifying Patients with Resectable Perihilar Cholangiocarcinoma Who Can Benefit from Portal Vein Embolization.
    Olthof PB; Wiggers JK; Groot Koerkamp B; Coelen RJ; Allen PJ; Besselink MG; Busch OR; D'Angelica MI; DeMatteo RP; Kingham TP; van Lienden KP; Jarnagin WR; van Gulik TM
    J Am Coll Surg; 2017 Sep; 225(3):387-394. PubMed ID: 28687509
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Estimation of postoperative mortality after partial liver resection for perihilar cholangiocarcinoma].
    Rauchfuß F; Settmacher U
    Chirurg; 2016 Jun; 87(6):534. PubMed ID: 27221662
    [No Abstract]   [Full Text] [Related]  

  • 31. [Klatskin tumor. A study of 15 resected cases].
    Santoro E; Sacchi M; Carboni F; Santoro R
    Chirurgie; 1999 Apr; 124(2):132-9; discussion 139-40. PubMed ID: 10349749
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Current status of laparoscopic radical hilar cholangiocarcinoma in Mainland China.
    Chen Y; Xu Y; Zhang Y
    Biosci Trends; 2020 Jul; 14(3):168-173. PubMed ID: 32389939
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic value of lymphovascular invasion in Bismuth-Corlette type IV hilar cholangiocarcinoma.
    Li B; Xiong XZ; Zhou Y; Wu SJ; You Z; Lu J; Cheng NS
    World J Gastroenterol; 2017 Sep; 23(36):6685-6693. PubMed ID: 29085213
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recurrence after curative-intent resection of perihilar cholangiocarcinoma: analysis of a large cohort with a close postoperative follow-up approach.
    Komaya K; Ebata T; Yokoyama Y; Igami T; Sugawara G; Mizuno T; Yamaguchi J; Nagino M
    Surgery; 2018 Apr; 163(4):732-738. PubMed ID: 29336813
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Right-side versus left-side hepatectomy for the treatment of hilar cholangiocarcinoma: a comparative study.
    Jo HS; Kim DS; Yu YD; Kang WH; Yoon KC
    World J Surg Oncol; 2020 Jan; 18(1):3. PubMed ID: 31901228
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Perioperative and long-term outcome of intrahepatic cholangiocarcinoma involving the hepatic hilus after curative-intent resection: comparison with peripheral intrahepatic cholangiocarcinoma and hilar cholangiocarcinoma.
    Zhang XF; Bagante F; Chen Q; Beal EW; Lv Y; Weiss M; Popescu I; Marques HP; Aldrighetti L; Maithel SK; Pulitano C; Bauer TW; Shen F; Poultsides GA; Soubrane O; Martel G; Koerkamp BG; Guglielmi A; Itaru E; Pawlik TM
    Surgery; 2018 May; 163(5):1114-1120. PubMed ID: 29398035
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic factors and long-term outcomes of hilar cholangiocarcinoma: A single-institution experience in China.
    Hu HJ; Mao H; Shrestha A; Tan YQ; Ma WJ; Yang Q; Wang JK; Cheng NS; Li FY
    World J Gastroenterol; 2016 Feb; 22(8):2601-10. PubMed ID: 26937148
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Postoperative Pancreatic Fistula in Surgery for Perihilar Cholangiocarcinoma.
    Watanabe N; Ebata T; Yokoyama Y; Igami T; Mizuno T; Yamaguchi J; Onoe S; Nagino M
    World J Surg; 2019 Dec; 43(12):3094-3100. PubMed ID: 31407095
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Value of E-PASS models for predicting postoperative morbidity and mortality in resection of perihilar cholangiocarcinoma and gallbladder carcinoma.
    Haga Y; Miyamoto A; Wada Y; Takami Y; Takeuchi H
    HPB (Oxford); 2016 Mar; 18(3):271-8. PubMed ID: 27017167
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evolution of surgery for Klatskin tumor demonstrates improved outcome: a single center analysis.
    Yan Y; Lu N; Tian W; Liu T
    Tumori; 2014; 100(6):e250-6. PubMed ID: 25688507
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.